IPAB holds an important decision on compulsory license for cancer drug ‘Nexavar’

Compulsory license makes it compulsory for the owner of a patent to license the use of their rights against payment either set by law or determined by arbitration. A company seeking to use a patent can do so without seeking the patent holder's consent, and pays the patent holder a set fee for the [...]